Polar Asset Management Partners’s Pliant Therapeutics PLRX Stock Holding History

Polar Asset Management Partners’s Portfolio PLRX Stock Details PLRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-62,600	Closed	-$824K	–	688
2024 Q4	$824K	Sell	62,600 -107,600	-63%	-$1.47M	0.01%	456
2024 Q3	$1.91M	Buy	170,200 +123,600	+265%	+$1.55M	0.04%	347
2024 Q2	$501K	Sell	46,600 -18,700	-29%	-$241K	0.01%	429
2024 Q1	$973K	Buy	+65,300	New	+$1.08M	0.02%	441
2023 Q4	–	Sell	-124,000	Closed	-$2.15M	–	883
2023 Q3	$2.15M	Buy	+124,000	New	+$2.15M	0.05%	381

Other funds holding PLRX

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

BOCH

Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

TGI

TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Polar Asset Management Partners's PLRX Position: Q1 2025 in Review

Polar Asset Management Partners sold out of Pliant Therapeutics (PLRX) in Q1 2025, closing a stake of 62,600 shares — an estimated $824K sold.

Polar Asset Management Partners first reported a position in PLRX in Q3 2023 and held it in 5 quarters. The position peaked at $2.15M in Q3 2023. 140 funds tracked by Wall St. Rank hold PLRX as of Q1 2025.

Polar Asset Management Partners reported no remaining Pliant Therapeutics position as of Q1 2025 after selling out during the quarter.
Polar Asset Management Partners sold 62,600 Pliant Therapeutics shares in Q1 2025, an estimated $824K.
Polar Asset Management Partners first reported a position in Pliant Therapeutics in Q3 2023 and held it in 5 quarters.
Polar Asset Management Partners's Pliant Therapeutics position peaked at $2.15M in Q3 2023.
140 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q1 2025.

Based on Polar Asset Management Partners's 13F filing for Q1 2025, filed 15 May 2025.